Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Zai Lab Ltd (ZLAB)

23.49 -0.41 (-1.72%)

02-16 16:00

Open:

23.72

Pre. Close:

23.9

High:

23.99

Low:

23.12

Volume:

61,404

Market Cap:

1158M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

24.015 - 24.146

24.146 - 24.255

Low:

22.894 - 23.056

23.056 - 23.191

Close:

23.243 - 23.493

23.493 - 23.701

Technical analysis  (as of: 2018-02-16 4:26:58 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 28.57     One year: 31.93

Support:

Support1: 19.80    Support2: 16.47

Resistance:

Resistance1: 24.46    Resistance2: 27.34

Pivot:

23.65

Moving Averages:

MA(5): 22.88     MA(20): 23.76

MA(100): 25.58     MA(250):

MACD:

MACD(12,26): -0.27     Signal(12,26,9): -0.25

%K %D:

%K(14,3): 53.98     %D(3): 45.02

RSI:

RSI(14): 50.33

52-Week:

High: 35.74  Low: 19.8  Change(%): -15.9

Average Vol(K):

3-Month: 8310  10-Days 11865

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ZLAB has closed above bottom band by 48.1%. Bollinger Bands are 0% narrower than normal.

Headline News

Wed, 07 Feb 2018 21:00:00 GMT
Zai Lab Limited to present at the Leerink Partners 7th Annual Global ...

Wed, 03 Jan 2018 21:00:00 GMT
Zai Lab Limited to present at the 36th Annual JP Morgan Healthcare Conference

Tue, 19 Sep 2017 17:24:54 GMT
Zai Lab Updates Proposed $100 Million US IPO Terms

Fri, 22 Sep 2017 20:03:45 GMT
Zai Lab Limited Announces Closing of US Initial Public Offering of ADSs

Fri, 29 Sep 2017 12:00:00 GMT
Zai Lab Limited Announces Dosing of First Patient in Phase 3 Registration ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

49.31

Shares Float (M)

49.31

% Held by Insiders

% Held by Institutions

18.10

Shares Short (K)

1232

Shares Short Prior Month (K)

632

Stock Financials

EPS

EPS Est. Current Year

-1.240

EPS Est. Next Year

-1.010

EPS Est. Next Quarter

Forward EPS

-1.010

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-48.2

Return on Equity (ttm)

21.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-41.03

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

P/CF

-28.23

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.